Medicare Enrolled
Dr. Harpreet Parmar, MD
Cardiovascular Disease · Lodi, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parmar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parmar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parmar
Dr. Harpreet Parmar is a cardiovascular disease specialist in Lodi, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Parmar performed 5,119 Medicare services across 3,833 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parmar received a total of $5,589 from 36 pharmaceutical and/or device companies across 280 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parmar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 19% volume in CA
$5,589 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,119
Medicare services
Top 19% in CA for cardiovascular disease
3,833
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~284 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
2,168 | $6 | $51 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,028 | $92 | $343 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
269 | $150 | $716 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
193 | $10 | $79 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
191 | $68 | $234 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
140 | $19 | $111 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
110 | $24 | $133 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
108 | $42 | $150 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
98 | $27 | $166 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
97 | $142 | $663 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
74 | $139 | $461 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
63 | $144 | $957 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
56 | $77 | $318 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $122 | $521 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
49 | $10 | $60 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
49 | $20 | $95 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
44 | $98 | $544 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
35 | $84 | $459 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
29 | $52 | $311 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
29 | $27 | $254 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
28 | $380 | $2,149 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
28 | $162 | $869 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $65 | $238 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
25 | $175 | $927 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
22 | $66 | $430 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
20 | $24 | $145 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
17 | $194 | $906 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
17 | $10 | $215 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $106 | $450 |
| Cardiac catheterization | 15 | $206 | $1,296 |
| New patient office visit, complex (60-74 min) | 13 | $164 | $656 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
11 | $97 | $345 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.3% high complexity
8.9% medium
77.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,589
Total received (2018-2024)
Avg $798/year across 7 years
Top 38% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
280
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,452 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$136 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$194
2023
$113
2022
$303
2021
$119
2020
$532
2019
$1,760
2018
$2,567
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$119
Novartis Pharmaceuticals Corporation
$49
PFIZER INC.
$26
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTRONIK INC.
$1,036
Boehringer Ingelheim Pharmaceuticals, Inc.
$605
Janssen Pharmaceuticals, Inc
$429
PFIZER INC.
$367
AstraZeneca Pharmaceuticals LP
$329
Novartis Pharmaceuticals Corporation
$303
Kowa Pharmaceuticals America, Inc.
$280
E.R. Squibb & Sons, L.L.C.
$279
Gilead Sciences, Inc.
$157
Amgen Inc.
$144
Otsuka America Pharmaceutical, Inc.
$144
Boston Scientific Corporation
$141
Bayer HealthCare Pharmaceuticals Inc.
$133
ShockWave Medical, Inc
$119
Regeneron Healthcare Solutions, Inc.
$113
Amarin Pharma Inc.
$106
SANOFI-AVENTIS U.S. LLC
$95
Astellas Pharma US Inc
$90
United Therapeutics Corporation
$85
Braemar Manufacturing, LLC
$81
Medtronic Vascular, Inc.
$77
Medtronic, Inc.
$66
iRhythm Technologies, Inc.
$55
Lundbeck LLC
$51
Novo Nordisk Inc
$46
Relypsa, Inc.
$43
ARBOR PHARMACEUTICALS, INC.
$34
PORTOLA PHARMACEUTICALS, INC.
$30
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$29
Lilly USA, LLC
$27
Allergan Inc.
$19
Abbott Laboratories
$19
Preventice Services, LLC
$18
Silk Road Medical, Inc.
$14
Cardiovascular Systems Inc.
$12
Philips Electronics North America Corporation
$12
Top 3 companies account for 37.0% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · ANDEXXA · Adempas · BG Mini Plus · BREATHTEK · BRILINTA · CHANTIX · Cardiac Monitoring Suite · CardioMEMS HF System · Corlanor · ELIQUIS · EMBLEM · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · GENERAL PAIN MANAGEMENT · JARDIANCE · JYNARQUE · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LINQ II · LUX-DX · LifeVest · Livalo · MULTAQ · Micra · NORTHERA · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · REMODULIN · Repatha · Reveal LINQ · SAMSCA · STIOLTO RESPIMAT · SUPERION · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TRULICITY · VIIBRYD · Vascepa · Veltassa · Wegovy · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
30
Per 100K population
3.8
County median income
$88,531
Nearest hospital
ADVENTIST HEALTH LODI MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parmar is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parmar experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Parmar performed 2,168 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parmar receive payments from pharmaceutical companies?
Yes. Dr. Parmar received a total of $5,589 from 36 companies across 280 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parmar's costs compare to other cardiologists in Lodi?
Dr. Parmar's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parmar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Lodi
Browse cardiologists in Lodi ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology